IFM Investors’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14M | Buy |
35,839
+2,319
| +7% | +$980K | 0.09% | 204 |
|
|
2026
Q1 | $15.9M | Sell |
33,520
-301
| -0.9% | -$152K | 0.13% | 147 |
|
|
2025
Q4 | $15.8M | Sell |
33,821
-2,548
| -7% | -$1.18M | 0.13% | 134 |
|
|
2025
Q3 | $15.2M | Sell |
36,369
-1,008
| -3% | -$391K | 0.13% | 137 |
|
|
2025
Q2 | $14.3M | Buy |
37,377
+225
| +0.6% | +$81.1K | 0.14% | 140 |
|
|
2025
Q1 | $12.8M | Hold |
37,152
| – | – | 0.14% | 140 |
|
|
2024
Q4 | $11.2M | Sell |
37,152
-3,781
| -9% | -$1.32M | 0.11% | 174 |
|
|
2024
Q3 | $16.6M | Sell |
40,933
-183
| -0.4% | -$67K | 0.16% | 119 |
|
|
2024
Q2 | $13.2M | Sell |
41,116
-142
| -0.3% | -$46.1K | 0.13% | 144 |
|
|
2024
Q1 | $13.8M | Sell |
41,258
-719
| -2% | -$220K | 0.15% | 134 |
|
|
2023
Q4 | $11.4M | Sell |
41,977
-1,156
| -3% | -$286K | 0.14% | 149 |
|
|
2023
Q3 | $10.6M | Buy |
43,133
+1,323
| +3% | +$362K | 0.14% | 139 |
|
|
2023
Q2 | $12.7M | Buy |
41,810
+90
| +0.2% | +$25K | 0.17% | 120 |
|
|
2023
Q1 | $11M | Sell |
41,720
-435
| -1% | -$110K | 0.17% | 123 |
|
|
2022
Q4 | $10.1M | Sell |
42,155
-25
| -0.1% | -$5.6K | 0.17% | 133 |
|
|
2022
Q3 | $7.75M | Buy |
42,180
+333
| +0.8% | +$66.3K | 0.14% | 153 |
|
|
2022
Q2 | $7.03M | Hold |
41,847
| – | – | 0.12% | 173 |
|
|
2022
Q1 | $10.5M | Buy |
41,847
+6,181
| +17% | +$1.55M | 0.16% | 126 |
|
|
2021
Q4 | $9.16M | Sell |
35,666
-382
| -1% | -$93.5K | 0.17% | 117 |
|
|
2021
Q3 | $8.75M | Sell |
36,048
-84
| -0.2% | -$20.5K | 0.18% | 109 |
|
|
2021
Q2 | $7.47M | Buy |
36,132
+6,037
| +20% | +$1.23M | 0.15% | 138 |
|
|
2021
Q1 | $5.67M | Buy |
30,095
+3,972
| +15% | +$700K | 0.15% | 134 |
|
|
2020
Q4 | $4.3M | Buy |
26,123
+3,842
| +17% | +$562K | 0.14% | 143 |
|
|
2020
Q3 | $2.78M | Buy |
22,281
+2,330
| +12% | +$288K | 0.12% | 166 |
|
|
2020
Q2 | $1.94M | Sell |
19,951
-7,596
| -28% | -$790K | 0.1% | 202 |
|
|
2020
Q1 | $2.51M | Sell |
27,547
-1,037
| -4% | -$134K | 0.11% | 174 |
|
|
2019
Q4 | $4.22M | Sell |
28,584
-1,375
| -5% | -$185K | 0.15% | 154 |
|
|
2019
Q3 | $3.61M | Buy |
29,959
+9,925
| +50% | +$1.28M | 0.13% | 171 |
|
|
2019
Q2 | $2.71M | Buy |
20,034
+1,471
| +8% | +$186K | 0.15% | 146 |
|
|
2019
Q1 | $2.42M | Buy |
18,563
+2,488
| +15% | +$334K | 0.16% | 146 |
|
|
2018
Q4 | $2M | Buy |
16,075
+1,348
| +9% | +$181K | 0.16% | 138 |
|
|
2018
Q3 | $2.05M | Buy |
14,727
+2,196
| +18% | +$273K | 0.16% | 144 |
|
|
2018
Q2 | $1.29M | Buy |
12,531
+3,834
| +44% | +$388K | 0.12% | 179 |
|
|
2018
Q1 | $844K | Buy |
8,697
+656
| +8% | +$63.6K | 0.12% | 184 |
|
|
2017
Q4 | $706K | Sell |
8,041
-80
| -1% | -$6.43K | 0.11% | 204 |
|
|
2017
Q3 | $646K | Sell |
8,121
-150
| -2% | -$12.1K | 0.11% | 217 |
|
|
2017
Q2 | $721K | Buy |
8,271
+2,056
| +33% | +$174K | 0.13% | 184 |
|
|
2017
Q1 | $553K | Buy |
6,215
+2,240
| +56% | +$187K | 0.14% | 173 |
|
|
2016
Q4 | $294K | Buy |
+3,975
| New | +$298K | 0.14% | 195 |
|
Other funds holding HCA
MC
LDB
MIHAS
ACM
FWIA
ET
SJL
IFM Investors's HCA Position: Q2 2026 in Review
IFM Investors increased its HCA Healthcare (HCA) stake by 6.9% in Q2 2026, buying an estimated $980K and bringing the position to 35,839 shares worth $14M. The position accounts for 0.09% of the portfolio, ranked #204.
IFM Investors first reported a position in HCA in Q4 2016 and has held it in 39 quarters since. The position peaked at $16.6M in Q3 2024. 342 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- IFM Investors held 35,839 shares of HCA Healthcare worth $14M as of Q2 2026.
- IFM Investors bought 2,319 HCA Healthcare shares in Q2 2026, an estimated $980K.
- HCA Healthcare made up 0.09% of IFM Investors's portfolio in Q2 2026, its #204 holding.
- IFM Investors first reported a position in HCA Healthcare in Q4 2016 and has held it in 39 quarters since.
- IFM Investors's HCA Healthcare position peaked at $16.6M in Q3 2024.
- 342 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.